For NPC cells, our previous studies have shown that the anticancer drug luteolin-7-O-glucoside modulated proliferation and apoptosis through the Akt signaling pathway [41], and that celastrol caused cell cycle G2/M phase arrest and apoptosis via ERK and p38 signaling pathways [42]. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.